Contact us on +44 (0)1270 270010 | info@boydconsultants.com

Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
December 18, 2020 SueCarr

A reminder that the Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019 will come into force on exit day – 1 January 2021.

 

Legislation in full:
Title Years & Numbers
The medicines for human use (clinical trials) (Amendment) (EU Exit) Regulations 2019 2019 – No. 744
The medicines for human use (clinical trials) and Blood Safety and Quality (Amendment) Regulations 2008 2008 – No. 941
The medicines for human use (clinical trials) Amendment (No. 2) Regulations 2006 2006 – No. 2984
The medicines for human use (clinical trials) Amendment Regulations 2006 2006 – No. 1928
The medicines for human use (clinical trials) Regulations 2004 2004 – No. 1031
And for ATMPs:
The Medicines for Human Use (Advanced Therapy Medicinal Products and Miscellaneous Amendments) Regulations 2010 2010 – No. 1882